Overexpression of estrogen receptor α increases hepatic cholesterogenesis, leading to biliary hypersecretion in mice

Helen H. Wang, Nezam H. Afdhal, David Q.H. Wang

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

We explored whether there is an "estrogen-ERα-SREBP-2" (for estrogen-estrogen receptor subtype α-sterol-regulatory element binding protein-2) pathway for regulating hepatic cholesterol biosynthesis in ovariectomized AKR mice treated with 17β-estradial (E2) at 6 μg/day or E2 plus the antiestrogenic agent ICI 182,780 at 125 μg/day and on chow or fed a high-cholesterol (1%) diet for 14 days. To monitor changes in cholesterol biosynthesis and newly synthesized cholesterol secreted into bile, incorporation into digitonin-precipitable sterols in mice treated with 25 mCi of [3H]water was measured in extracts of liver and extrahepatic organs 1 h later and in hepatic biles 6 h later. ERα upregulated SREBP-2, with resulting activation of SREBP-2-responsive genes in the cholesterol biosynthetic pathway. The E2-treated mice continued to synthesize cholesterol in spite of its excess availability from high dietary cholesterol, which reflects a loss in controlling the negative feedback regulation of cholesterol synthesis. These alterations augmented biliary cholesterol secretion and enhanced the lithogenicity of bile. However, these lithogenic effects of E2 were fully blocked by ICI 182,780. We conclude that during estrogen treatment, more newly synthesized cholesterol determined by the estrogen-ERα-SREBP-2 pathway is secreted into bile, leading to biliary cholesterol hypersecretion. These studies provide insights into therapeutic approaches to cholesterol gallstones in high-risk subjects, especially those exposed to high levels of estrogen.

Original languageEnglish (US)
Pages (from-to)778-786
Number of pages9
JournalJournal of Lipid Research
Volume47
Issue number4
DOIs
StatePublished - Apr 1 2006
Externally publishedYes

Fingerprint

Estrogen Receptors
Cholesterol
Liver
Estrogens
Bile
Biosynthesis
Sterol Regulatory Element Binding Protein 2
Inbred AKR Mouse
Dietary Cholesterol
Digitonin
Liver Extracts
Biosynthetic Pathways
Gallstones
Sterols
Nutrition
Genes
Chemical activation
Availability
Diet
Feedback

Keywords

  • Bile
  • Bile flow
  • Bile salt
  • Biliary secretion
  • Cholesterol saturation index
  • Crystallization
  • Liquid crystals
  • Microscopy

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology
  • Cell Biology

Cite this

Overexpression of estrogen receptor α increases hepatic cholesterogenesis, leading to biliary hypersecretion in mice. / Wang, Helen H.; Afdhal, Nezam H.; Wang, David Q.H.

In: Journal of Lipid Research, Vol. 47, No. 4, 01.04.2006, p. 778-786.

Research output: Contribution to journalArticle

@article{4725eeb15ec34e5e9098cdfe86662c76,
title = "Overexpression of estrogen receptor α increases hepatic cholesterogenesis, leading to biliary hypersecretion in mice",
abstract = "We explored whether there is an {"}estrogen-ERα-SREBP-2{"} (for estrogen-estrogen receptor subtype α-sterol-regulatory element binding protein-2) pathway for regulating hepatic cholesterol biosynthesis in ovariectomized AKR mice treated with 17β-estradial (E2) at 6 μg/day or E2 plus the antiestrogenic agent ICI 182,780 at 125 μg/day and on chow or fed a high-cholesterol (1{\%}) diet for 14 days. To monitor changes in cholesterol biosynthesis and newly synthesized cholesterol secreted into bile, incorporation into digitonin-precipitable sterols in mice treated with 25 mCi of [3H]water was measured in extracts of liver and extrahepatic organs 1 h later and in hepatic biles 6 h later. ERα upregulated SREBP-2, with resulting activation of SREBP-2-responsive genes in the cholesterol biosynthetic pathway. The E2-treated mice continued to synthesize cholesterol in spite of its excess availability from high dietary cholesterol, which reflects a loss in controlling the negative feedback regulation of cholesterol synthesis. These alterations augmented biliary cholesterol secretion and enhanced the lithogenicity of bile. However, these lithogenic effects of E2 were fully blocked by ICI 182,780. We conclude that during estrogen treatment, more newly synthesized cholesterol determined by the estrogen-ERα-SREBP-2 pathway is secreted into bile, leading to biliary cholesterol hypersecretion. These studies provide insights into therapeutic approaches to cholesterol gallstones in high-risk subjects, especially those exposed to high levels of estrogen.",
keywords = "Bile, Bile flow, Bile salt, Biliary secretion, Cholesterol saturation index, Crystallization, Liquid crystals, Microscopy",
author = "Wang, {Helen H.} and Afdhal, {Nezam H.} and Wang, {David Q.H.}",
year = "2006",
month = "4",
day = "1",
doi = "10.1194/jlr.M500454-JLR200",
language = "English (US)",
volume = "47",
pages = "778--786",
journal = "Journal of Lipid Research",
issn = "0022-2275",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "4",

}

TY - JOUR

T1 - Overexpression of estrogen receptor α increases hepatic cholesterogenesis, leading to biliary hypersecretion in mice

AU - Wang, Helen H.

AU - Afdhal, Nezam H.

AU - Wang, David Q.H.

PY - 2006/4/1

Y1 - 2006/4/1

N2 - We explored whether there is an "estrogen-ERα-SREBP-2" (for estrogen-estrogen receptor subtype α-sterol-regulatory element binding protein-2) pathway for regulating hepatic cholesterol biosynthesis in ovariectomized AKR mice treated with 17β-estradial (E2) at 6 μg/day or E2 plus the antiestrogenic agent ICI 182,780 at 125 μg/day and on chow or fed a high-cholesterol (1%) diet for 14 days. To monitor changes in cholesterol biosynthesis and newly synthesized cholesterol secreted into bile, incorporation into digitonin-precipitable sterols in mice treated with 25 mCi of [3H]water was measured in extracts of liver and extrahepatic organs 1 h later and in hepatic biles 6 h later. ERα upregulated SREBP-2, with resulting activation of SREBP-2-responsive genes in the cholesterol biosynthetic pathway. The E2-treated mice continued to synthesize cholesterol in spite of its excess availability from high dietary cholesterol, which reflects a loss in controlling the negative feedback regulation of cholesterol synthesis. These alterations augmented biliary cholesterol secretion and enhanced the lithogenicity of bile. However, these lithogenic effects of E2 were fully blocked by ICI 182,780. We conclude that during estrogen treatment, more newly synthesized cholesterol determined by the estrogen-ERα-SREBP-2 pathway is secreted into bile, leading to biliary cholesterol hypersecretion. These studies provide insights into therapeutic approaches to cholesterol gallstones in high-risk subjects, especially those exposed to high levels of estrogen.

AB - We explored whether there is an "estrogen-ERα-SREBP-2" (for estrogen-estrogen receptor subtype α-sterol-regulatory element binding protein-2) pathway for regulating hepatic cholesterol biosynthesis in ovariectomized AKR mice treated with 17β-estradial (E2) at 6 μg/day or E2 plus the antiestrogenic agent ICI 182,780 at 125 μg/day and on chow or fed a high-cholesterol (1%) diet for 14 days. To monitor changes in cholesterol biosynthesis and newly synthesized cholesterol secreted into bile, incorporation into digitonin-precipitable sterols in mice treated with 25 mCi of [3H]water was measured in extracts of liver and extrahepatic organs 1 h later and in hepatic biles 6 h later. ERα upregulated SREBP-2, with resulting activation of SREBP-2-responsive genes in the cholesterol biosynthetic pathway. The E2-treated mice continued to synthesize cholesterol in spite of its excess availability from high dietary cholesterol, which reflects a loss in controlling the negative feedback regulation of cholesterol synthesis. These alterations augmented biliary cholesterol secretion and enhanced the lithogenicity of bile. However, these lithogenic effects of E2 were fully blocked by ICI 182,780. We conclude that during estrogen treatment, more newly synthesized cholesterol determined by the estrogen-ERα-SREBP-2 pathway is secreted into bile, leading to biliary cholesterol hypersecretion. These studies provide insights into therapeutic approaches to cholesterol gallstones in high-risk subjects, especially those exposed to high levels of estrogen.

KW - Bile

KW - Bile flow

KW - Bile salt

KW - Biliary secretion

KW - Cholesterol saturation index

KW - Crystallization

KW - Liquid crystals

KW - Microscopy

UR - http://www.scopus.com/inward/record.url?scp=33645539153&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645539153&partnerID=8YFLogxK

U2 - 10.1194/jlr.M500454-JLR200

DO - 10.1194/jlr.M500454-JLR200

M3 - Article

C2 - 16380638

AN - SCOPUS:33645539153

VL - 47

SP - 778

EP - 786

JO - Journal of Lipid Research

JF - Journal of Lipid Research

SN - 0022-2275

IS - 4

ER -